Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: M.D. Anderson Cancer Center
Condition: CCND1 Positive, CD20-Positive Neoplastic Cells Present, Mantle Cell Lymphoma
NCT03232307
Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell Lymphoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Sponsor does not wish to proceed